[go: up one dir, main page]

AU2007333220A1 - Remotely triggered release from heatable surfaces - Google Patents

Remotely triggered release from heatable surfaces Download PDF

Info

Publication number
AU2007333220A1
AU2007333220A1 AU2007333220A AU2007333220A AU2007333220A1 AU 2007333220 A1 AU2007333220 A1 AU 2007333220A1 AU 2007333220 A AU2007333220 A AU 2007333220A AU 2007333220 A AU2007333220 A AU 2007333220A AU 2007333220 A1 AU2007333220 A1 AU 2007333220A1
Authority
AU
Australia
Prior art keywords
conjugate
agent
thermally
agents
delivered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2007333220A
Other languages
English (en)
Inventor
Sangeeta N. Bhatia
Austin M. Derfus
Geoffrey Von Maltzahn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California San Diego UCSD
Original Assignee
University of California Berkeley
University of California San Diego UCSD
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California Berkeley, University of California San Diego UCSD filed Critical University of California Berkeley
Publication of AU2007333220A1 publication Critical patent/AU2007333220A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0028—Disruption, e.g. by heat or ultrasounds, sonophysical or sonochemical activation, e.g. thermosensitive or heat-sensitive liposomes, disruption of calculi with a medicinal preparation and ultrasounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6903—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being semi-solid, e.g. an ointment, a gel, a hydrogel or a solidifying gel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
    • A61K47/6923—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being an inorganic particle, e.g. ceramic particles, silica particles, ferrite or synsorb
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
    • A61K49/0069—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form
    • A61K49/0089—Particulate, powder, adsorbate, bead, sphere
    • A61K49/0091—Microparticle, microcapsule, microbubble, microsphere, microbead, i.e. having a size or diameter higher or equal to 1 micrometer
    • A61K49/0093—Nanoparticle, nanocapsule, nanobubble, nanosphere, nanobead, i.e. having a size or diameter smaller than 1 micrometer, e.g. polymeric nanoparticle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
    • A61K49/1821—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
    • A61K49/1824—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nanotechnology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Ceramic Engineering (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Radiology & Medical Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Thermotherapy And Cooling Therapy Devices (AREA)
AU2007333220A 2006-12-08 2007-12-07 Remotely triggered release from heatable surfaces Abandoned AU2007333220A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US87389706P 2006-12-08 2006-12-08
US60/873,897 2006-12-08
US96938907P 2007-08-31 2007-08-31
US60/969,389 2007-08-31
PCT/US2007/086863 WO2008073851A2 (fr) 2006-12-08 2007-12-07 Libération déclenchée à distance depuis des surfaces pouvant être chauffées

Publications (1)

Publication Number Publication Date
AU2007333220A1 true AU2007333220A1 (en) 2008-06-19

Family

ID=40427804

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2007333220A Abandoned AU2007333220A1 (en) 2006-12-08 2007-12-07 Remotely triggered release from heatable surfaces

Country Status (4)

Country Link
EP (1) EP2117595A2 (fr)
AU (1) AU2007333220A1 (fr)
CA (1) CA2671806A1 (fr)
WO (1) WO2008073851A2 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011026294A (ja) * 2009-06-26 2011-02-10 Canon Inc 化合物
EP2490723A1 (fr) * 2009-10-19 2012-08-29 University Of Louisville Research Foundation, Inc. Nanoparticules pour l'administration de médicaments
DE102009058769A1 (de) * 2009-12-16 2011-06-22 MagForce Nanotechnologies AG, 10589 Temperaturabhängige Aktivierung von katalytischen Nukleinsäuren zur kontrollierten Wirkstofffreisetzung
WO2012158631A2 (fr) * 2011-05-13 2012-11-22 The Regents Of The University Of California Substrats photothermiques pour transfection sélective de cellules
WO2014049566A2 (fr) * 2012-09-28 2014-04-03 Stellenbosch University Kit nutritionnel
CA2905999A1 (fr) 2013-03-15 2014-09-25 The Regents Of The University Of California Administration de charges a haut debit dans des cellules vivantes au moyen de plates-formes photothermiques
CN106460011A (zh) 2014-03-28 2017-02-22 加利福尼亚大学董事会 大运输物向多孔基质上的细胞中的高效递送
US11559494B2 (en) 2017-07-14 2023-01-24 The Penn State Research Foundation Compositions and methods for targeted delivery of therapeutic and/or diagnostic species
EP3501334B1 (fr) 2017-12-20 2020-06-24 The Gillette Company LLC Outil de soin buccal
CN110404084B (zh) * 2019-08-21 2020-10-23 青岛大学 一种基于dna光热熔融的纳米粒子与制备方法及应用
CN112300410B (zh) * 2020-11-05 2022-07-15 云南师范大学 一种多孔结构的水凝胶复合材料及其制备与应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001056546A2 (fr) * 2000-02-05 2001-08-09 Florida State University Research Foundation Composition a base de magnetoliposomes, destinee au traitement cible d'un tissu biologique, et procedes associes
DE10224352A1 (de) * 2002-06-01 2003-12-11 Mueller Schulte Detlef Thermosensitive Polymerträger mit veränderbarer physikalischer Struktur für die biochemische Analytik, Diagnostik und Therapie
US20060025713A1 (en) * 2003-05-12 2006-02-02 Alex Rosengart Magnetic particle-based therapy
DE10350248A1 (de) * 2003-10-28 2005-06-16 Magnamedics Gmbh Thermosensitive, biokompatible Polymerträger mit veränderbarer physikalischer Struktur für die Therapie, Diagnostik und Analytik
WO2005065282A2 (fr) * 2003-12-31 2005-07-21 The Regents Of The University Of California Procedes et articles de traitement magnetique a distance de cancers et autres maladies et procedes pour faire fonctionner un tel article
WO2005109313A2 (fr) * 2004-04-29 2005-11-17 The Regents Of The University Of California Encapsulation de medicaments avec des oligonucleotides synthetiques
DE102005016873A1 (de) * 2005-04-12 2006-10-19 Magforce Nanotechnologies Ag Nanopartikel-Wirstoff-Konjugate
WO2007021236A1 (fr) * 2005-08-19 2007-02-22 Genovis Ab Nanoparticule appropriée pour la remise d'une biomolécule dans ou hors d'une cellule logée dans une membrane ou d'une organelle cellulaire
KR100819378B1 (ko) * 2006-02-24 2008-04-04 (주)에이티젠 양친매성 화합물을 이용한 자성 나노복합체 및 이를포함하는 약제학적 조성물
WO2007116954A2 (fr) * 2006-03-30 2007-10-18 Fujifilm Corporation Nanoparticule
US8017237B2 (en) * 2006-06-23 2011-09-13 Abbott Cardiovascular Systems, Inc. Nanoshells on polymers
RU2373957C2 (ru) * 2006-10-13 2009-11-27 Александр Метталинович Тишин Носитель для лекарственных средств и биологически активных веществ для лечения и диагностики и применение его для создания лекарственных средств и способа регулируемой управляемой доставки лекарственного средства или биологически активного вещества с регулируемой десорбцией его

Also Published As

Publication number Publication date
EP2117595A2 (fr) 2009-11-18
WO2008073851A3 (fr) 2009-05-22
CA2671806A1 (fr) 2008-06-19
WO2008073851A2 (fr) 2008-06-19

Similar Documents

Publication Publication Date Title
US20090093551A1 (en) Remotely triggered release from heatable surfaces
AU2007333220A1 (en) Remotely triggered release from heatable surfaces
CA2648099C (fr) Systeme pour l'administration ciblee d'agents therapeutiques
US20110052697A1 (en) Aptamer-Directed Drug Delivery
US20140314864A1 (en) System for Targeted Delivery of Therapeutic Agents
US20130071329A1 (en) Theranostic delivery systems with modified surfaces
US20110027172A1 (en) Drug delivery system for pharmaceuticals and radiation
WO2011133925A2 (fr) Administration cytosolique photoactivée et ciblée de médicament
JP6590809B2 (ja) カテコールで官能化された磁性ナノ粒子、その生成および使用
US20250345283A1 (en) Macrophage-derived engineered vesicles for targeted delivery and treatment
AU2014202199A1 (en) Delivery of nanoparticles and/or agents to cells
Bhattacharjee et al. Application of nano based drug delivery channel against leukemia chemotherapeutic resistance
Habra Investigating potential nano-and micro-drug delivery systems toward the non-invasive treatment of glioblastoma brain tumours
WO2019073371A1 (fr) Composition pharmaceutique comprenant des nanoparticules hybrides albumine-lipide
Khoshbin et al. Hybrid gold nanoparticles as advanced drug delivery and theranostics application
Joseph et al. Applications of Magnetically Modulated Systems
DEY et al. Success of Nanotherapy in the Treatment of Cancer-An Overview.
Tshikhudo et al. -Noble Metal Nanoparticles in Drug Delivery

Legal Events

Date Code Title Description
DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS: AMEND THE APPLICANT NAME FROM UNIVERSITY OF CALIFORNIA, SAN DIEGO TO THE REGENTS OF THE UNIVERSITY OF CALIFORNIA AND DELETE CO-APPLICANT MASSACHUSETTS INSTITUTE OF TECHNOLOGY

MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application